View Past PerformanceNufarm バランスシートの健全性財務の健全性 基準チェック /46Nufarmの総株主資本はA$2.1B 、総負債はA$1.4Bで、負債比率は70%となります。総資産と総負債はそれぞれA$4.8BとA$2.7Bです。 Nufarmの EBIT はA$106.0Mで、利息カバレッジ比率1です。現金および短期投資はA$358.0Mです。主要情報70.03%負債資本比率AU$1.44b負債インタレスト・カバレッジ・レシオ1x現金AU$358.05mエクイティAU$2.06b負債合計AU$2.74b総資産AU$4.80b財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Mar 28+ 1 more updateNufarm Limited to Report First Half, 2026 Results on May 27, 2026Nufarm Limited announced that they will report first half, 2026 results on May 27, 2026お知らせ • Nov 20Nufarm Limited, Annual General Meeting, Feb 04, 2026Nufarm Limited, Annual General Meeting, Feb 04, 2026. Location: hybrid meeting, Australiaお知らせ • May 27Nufarm Reportedly Receives Takeover Interest for NuseedAs of May 23, 2025 Nufarm Limited (ASX:NUF)'s share price was down about 38% over five days with its market value at $1 billion, close to the price at which the company's Seed Technologies unit Nuseed Pty. Ltd. is valued. The Seed Technologies unit is now subject to a UBS-run strategic review, which could lead to a sale, after groups such as BP and the KKR-backed Advanta Enterprises Limited expressed interest. A suitor may determine it is better to buy the entire company that was worth double what it is currently trading at a year ago, potentially attracting private -equity suitors. However, one deterrent could be its debt pile, with net debt at $1.36 billion. If a buyer for its $900 million Seed Technologies business cannot be sought, analysts are not ruling out an equity raising.お知らせ • Apr 29+ 1 more updateNufarm Limited to Report First Half, 2025 Results on May 21, 2025Nufarm Limited announced that they will report first half, 2025 results on May 21, 2025お知らせ • Mar 24Nufarm Limited(ASX:NUF) dropped from FTSE All-World Index (USD)Nufarm Limited(ASX:NUF) dropped from FTSE All-World Index (USD)お知らせ • Dec 12Nufarm Limited Announces Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary SupplementNutriterra®? Total Omega-3 has received Health Canada approval as an ingredient in dietary supplements. Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) issued a product license, Natural Product Number (NPN) 80136254, which authorizes it to be marketed and sold as a novel, canola-based total omega-3 oil with the following health claims: Supports heart health and cardiovascular function; Supports normal brain function; Source of docosahexaenoic acid (DHA) for maintaining good health; Source of alpha-linolenic acid (ALA) for maintaining good health; source of an essential fatty acid for the maintenance of good health; Source of omega-3 fatty acids for the maintenance of good health. Human clinical trials confirmed that Nutriterra's long-chain fatty acids are readily incorporated into blood lipids. Results were reviewed and authorized by NNHPD and published in Frontiers in Nutrition in 2022. A 2000 mg/day serving of Nutriterra significantly improved indicators of omega-3 status, including the OmegaScore™? and the Omega-3 Index, both of which are supportive of cardiovascular and brain health. While the health benefits of omega-3 fatty acids are well known, few people consume enough of these essential nutrients. Ms. Boettner attributes this to the sensory experiences and ocean health concerns associated with fish oil. This approval follows the Canadian Food Inspection Agency's 2020 approval of Nutriterra for food and feed applications, allowing for greater formulation flexibility for customers. Omega-3 Canola helps fill the gap between how much long-chain omega-3 is needed to support human health and how little the ocean can sustainably provide. Just one hectare of Nuseed Omega-3 canola produces as much DHA as 10,000 one kg wild caught fish. Nutriterra has a unique fatty acid profile with DHA, EPA, and ALA to support human nutrition. This Health Canada approval follows the US Food and Drug Administration (FDA) granting Nutriterra New Dietary Ingredient status in 2021. Having previously obtained food and feed approvals in Australia and New Zealand, the US, and Canada, the company is progressing with additional regulatory applications in other key markets around the world.お知らせ • Mar 06+ 2 more updatesNufarm Limited to Report First Half, 2024 Results on May 16, 2024Nufarm Limited announced that they will report first half, 2024 results on May 16, 2024お知らせ • Nov 22Nufarm Limited, Annual General Meeting, Feb 01, 2024Nufarm Limited, Annual General Meeting, Feb 01, 2024.お知らせ • Nov 17Nufarm Limited Announces Final Dividend for the Period of Six Months Ended 30 September 2023, Payable on 15 December 2023Nufarm Limited announced final dividend of AUD 0.05000000 per share for the period of six months ended 30 September 2023. Ex Date 22 November 2023, Record Date 23 November 2023 and Payment Date 15 December 2023.お知らせ • Nov 15Nufarm Limited Announces Director ResignationsNufarm Limited announced the resignation of Gordon Davis and Peter Margin as non-executive directors of the Nufarm board, effective November 15, 2023. This completes a 3-year period of board renewal. Gordon Davis joined the Nufarm board on 31 May 2011 following a distinguished executive career in the agribusiness and industrial sectors including as managing director of AWB and senior executive roles at Orica and Incitec Fertilizers. During his 12 year tenure at Nufarm, Gordon served on numerous board committees, including most recently as chair of the risk and compliance committee and previously as chair of the health, safety and environment committee. Peter Margin joined the Nufarm board on 3 October 2011, bringing a wealth of experience in consumer marketing, manufacturing and operations from his executive roles as managing director at National Foods and Goodman Fielder, in addition to his various non executive roles including at Bega Group, Costa and Asahi Beverages. Peter also served on numerous committees during his tenure, most notably chairing the human resources committee for more than 10 years.お知らせ • Jun 19Nufarm Limited Announces Board ChangesNufarm Limited announced the appointment of Adrian Percy and Federico Tripodi as independent, non-executive directors of the Nufarm Board. These appointments are the final step in a three-year board renewal process, which will conclude later this year with the previously announced retirements of long serving directors Peter Margin and Gordon Davis. Adrian is currently the inaugural Executive Director of the NC Plant Sciences Initiative at North Carolina State University. He has more than 30 years of experience in the agricultural sector, with previous roles as Chief Technology Officer of UPL Ltd. and Head of Research and Development for the Crop Science Division of Bayer. In the latter role, he was a member of their Executive Committee with responsibility for internal and open innovation activities in the areas of crop protection chemistry and biologicals, as well as seeds and traits. During his 25-year tenure at Bayer, he also held numerous positions in agricultural research and development. Adrian is a Venture Partner at Finistere Ventures LLC, a technology and life sciences venture capital investor. He also serves on the board of directors of BioLumic, AgPlenus, FA Bio and Evogene. Adrian holds a BSc from University of Liverpool, an MSc in Toxicology from University of Birmingham and a PhD in Biochemistry from University of Birmingham. He will take up his appointment to the Nufarm board with effect from 1 July 2023 and will stand for election at Nufarm’s Annual General Meeting (AGM) in February 2024. Federico has close to three-decades of involvement in the agri-food sector with his experience spanning general management, research and development, corporate strategy and the commercialization of novel plant biotechnologies targeted for consumers and farmers. Federico currently serves as Chairman at the Agricultural Utilization Research Institute (AURI). He is also the Founder and CEO of Blacktop Holdings, a boutique venture lab that offers strategic and operating partnership services to rapidly growing Ag Tech, Food and Agribusiness companies, their investors and research institutions. From 2016 to 2018, Federico served as the CEO of Calyxt Inc. Prior to Calyxt, Federico worked at Monsanto Company for nearly two decades where his primary focus was developing health, sustainability and renewable energy crop products in the United States and Latin America. Federico holds an MBA from Washington University’s Olin Business School, as well as an agronomic engineering degree from Buenos Aires University. He will take up his appointment to the Nufarm board with effect from today’s date and will stand for election at Nufarm’s AGM in February 2024.お知らせ • May 18Nufarm Limited Announces Distribution for the Six Months Ended March 31, 2023, Payable on June 9, 2023Nufarm Limited announced distribution of AUD 0.05000000 per share for the six months ended March 31, 2023. Record date is May 26, 2023. Ex-date is May 25, 2023. Payment date is June 9, 2023.お知らせ • Nov 18Nufarm Limited, Annual General Meeting, Feb 02, 2023Nufarm Limited, Annual General Meeting, Feb 02, 2023.財務状況分析短期負債: NUFM.Fの 短期資産 ( A$2.7B ) が 短期負債 ( A$1.3B ) を超えています。長期負債: NUFM.Fの短期資産 ( A$2.7B ) が 長期負債 ( A$1.5B ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: NUFM.Fの 純負債対資本比率 ( 52.7% ) は 高い と見なされます。負債の削減: NUFM.Fの負債対資本比率は、過去 5 年間で42.9%から70%に増加しました。貸借対照表キャッシュ・ランウェイ分析過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。安定したキャッシュランウェイ: 利益は出ていないものの、 NUFM.Fは現在のプラスの フリーキャッシュフロー レベルを維持すれば、3 年以上は十分な キャッシュランウェイ を有しています。キャッシュランウェイの予測: NUFM.Fは利益は出ていませんが、フリーキャッシュフローがプラスであり、年間23.1 % 増加しているため、3 年以上は十分なキャッシュランウェイがあります。健全な企業の発掘7D1Y7D1Y7D1YMaterials 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/18 15:37終値2026/06/18 00:00収益2026/03/31年間収益2025/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nufarm Limited 8 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。21 アナリスト機関Stephen WilderAlliance Global PartnersJonathan SnapeBell PotterReinhardt van der WaltBofA Global Research18 その他のアナリストを表示
お知らせ • Mar 28+ 1 more updateNufarm Limited to Report First Half, 2026 Results on May 27, 2026Nufarm Limited announced that they will report first half, 2026 results on May 27, 2026
お知らせ • Nov 20Nufarm Limited, Annual General Meeting, Feb 04, 2026Nufarm Limited, Annual General Meeting, Feb 04, 2026. Location: hybrid meeting, Australia
お知らせ • May 27Nufarm Reportedly Receives Takeover Interest for NuseedAs of May 23, 2025 Nufarm Limited (ASX:NUF)'s share price was down about 38% over five days with its market value at $1 billion, close to the price at which the company's Seed Technologies unit Nuseed Pty. Ltd. is valued. The Seed Technologies unit is now subject to a UBS-run strategic review, which could lead to a sale, after groups such as BP and the KKR-backed Advanta Enterprises Limited expressed interest. A suitor may determine it is better to buy the entire company that was worth double what it is currently trading at a year ago, potentially attracting private -equity suitors. However, one deterrent could be its debt pile, with net debt at $1.36 billion. If a buyer for its $900 million Seed Technologies business cannot be sought, analysts are not ruling out an equity raising.
お知らせ • Apr 29+ 1 more updateNufarm Limited to Report First Half, 2025 Results on May 21, 2025Nufarm Limited announced that they will report first half, 2025 results on May 21, 2025
お知らせ • Mar 24Nufarm Limited(ASX:NUF) dropped from FTSE All-World Index (USD)Nufarm Limited(ASX:NUF) dropped from FTSE All-World Index (USD)
お知らせ • Dec 12Nufarm Limited Announces Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary SupplementNutriterra®? Total Omega-3 has received Health Canada approval as an ingredient in dietary supplements. Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) issued a product license, Natural Product Number (NPN) 80136254, which authorizes it to be marketed and sold as a novel, canola-based total omega-3 oil with the following health claims: Supports heart health and cardiovascular function; Supports normal brain function; Source of docosahexaenoic acid (DHA) for maintaining good health; Source of alpha-linolenic acid (ALA) for maintaining good health; source of an essential fatty acid for the maintenance of good health; Source of omega-3 fatty acids for the maintenance of good health. Human clinical trials confirmed that Nutriterra's long-chain fatty acids are readily incorporated into blood lipids. Results were reviewed and authorized by NNHPD and published in Frontiers in Nutrition in 2022. A 2000 mg/day serving of Nutriterra significantly improved indicators of omega-3 status, including the OmegaScore™? and the Omega-3 Index, both of which are supportive of cardiovascular and brain health. While the health benefits of omega-3 fatty acids are well known, few people consume enough of these essential nutrients. Ms. Boettner attributes this to the sensory experiences and ocean health concerns associated with fish oil. This approval follows the Canadian Food Inspection Agency's 2020 approval of Nutriterra for food and feed applications, allowing for greater formulation flexibility for customers. Omega-3 Canola helps fill the gap between how much long-chain omega-3 is needed to support human health and how little the ocean can sustainably provide. Just one hectare of Nuseed Omega-3 canola produces as much DHA as 10,000 one kg wild caught fish. Nutriterra has a unique fatty acid profile with DHA, EPA, and ALA to support human nutrition. This Health Canada approval follows the US Food and Drug Administration (FDA) granting Nutriterra New Dietary Ingredient status in 2021. Having previously obtained food and feed approvals in Australia and New Zealand, the US, and Canada, the company is progressing with additional regulatory applications in other key markets around the world.
お知らせ • Mar 06+ 2 more updatesNufarm Limited to Report First Half, 2024 Results on May 16, 2024Nufarm Limited announced that they will report first half, 2024 results on May 16, 2024
お知らせ • Nov 22Nufarm Limited, Annual General Meeting, Feb 01, 2024Nufarm Limited, Annual General Meeting, Feb 01, 2024.
お知らせ • Nov 17Nufarm Limited Announces Final Dividend for the Period of Six Months Ended 30 September 2023, Payable on 15 December 2023Nufarm Limited announced final dividend of AUD 0.05000000 per share for the period of six months ended 30 September 2023. Ex Date 22 November 2023, Record Date 23 November 2023 and Payment Date 15 December 2023.
お知らせ • Nov 15Nufarm Limited Announces Director ResignationsNufarm Limited announced the resignation of Gordon Davis and Peter Margin as non-executive directors of the Nufarm board, effective November 15, 2023. This completes a 3-year period of board renewal. Gordon Davis joined the Nufarm board on 31 May 2011 following a distinguished executive career in the agribusiness and industrial sectors including as managing director of AWB and senior executive roles at Orica and Incitec Fertilizers. During his 12 year tenure at Nufarm, Gordon served on numerous board committees, including most recently as chair of the risk and compliance committee and previously as chair of the health, safety and environment committee. Peter Margin joined the Nufarm board on 3 October 2011, bringing a wealth of experience in consumer marketing, manufacturing and operations from his executive roles as managing director at National Foods and Goodman Fielder, in addition to his various non executive roles including at Bega Group, Costa and Asahi Beverages. Peter also served on numerous committees during his tenure, most notably chairing the human resources committee for more than 10 years.
お知らせ • Jun 19Nufarm Limited Announces Board ChangesNufarm Limited announced the appointment of Adrian Percy and Federico Tripodi as independent, non-executive directors of the Nufarm Board. These appointments are the final step in a three-year board renewal process, which will conclude later this year with the previously announced retirements of long serving directors Peter Margin and Gordon Davis. Adrian is currently the inaugural Executive Director of the NC Plant Sciences Initiative at North Carolina State University. He has more than 30 years of experience in the agricultural sector, with previous roles as Chief Technology Officer of UPL Ltd. and Head of Research and Development for the Crop Science Division of Bayer. In the latter role, he was a member of their Executive Committee with responsibility for internal and open innovation activities in the areas of crop protection chemistry and biologicals, as well as seeds and traits. During his 25-year tenure at Bayer, he also held numerous positions in agricultural research and development. Adrian is a Venture Partner at Finistere Ventures LLC, a technology and life sciences venture capital investor. He also serves on the board of directors of BioLumic, AgPlenus, FA Bio and Evogene. Adrian holds a BSc from University of Liverpool, an MSc in Toxicology from University of Birmingham and a PhD in Biochemistry from University of Birmingham. He will take up his appointment to the Nufarm board with effect from 1 July 2023 and will stand for election at Nufarm’s Annual General Meeting (AGM) in February 2024. Federico has close to three-decades of involvement in the agri-food sector with his experience spanning general management, research and development, corporate strategy and the commercialization of novel plant biotechnologies targeted for consumers and farmers. Federico currently serves as Chairman at the Agricultural Utilization Research Institute (AURI). He is also the Founder and CEO of Blacktop Holdings, a boutique venture lab that offers strategic and operating partnership services to rapidly growing Ag Tech, Food and Agribusiness companies, their investors and research institutions. From 2016 to 2018, Federico served as the CEO of Calyxt Inc. Prior to Calyxt, Federico worked at Monsanto Company for nearly two decades where his primary focus was developing health, sustainability and renewable energy crop products in the United States and Latin America. Federico holds an MBA from Washington University’s Olin Business School, as well as an agronomic engineering degree from Buenos Aires University. He will take up his appointment to the Nufarm board with effect from today’s date and will stand for election at Nufarm’s AGM in February 2024.
お知らせ • May 18Nufarm Limited Announces Distribution for the Six Months Ended March 31, 2023, Payable on June 9, 2023Nufarm Limited announced distribution of AUD 0.05000000 per share for the six months ended March 31, 2023. Record date is May 26, 2023. Ex-date is May 25, 2023. Payment date is June 9, 2023.
お知らせ • Nov 18Nufarm Limited, Annual General Meeting, Feb 02, 2023Nufarm Limited, Annual General Meeting, Feb 02, 2023.